Cizzle Biotechnology Holdings Plc (LON: CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.630
-0.120 (-6.86%)
Dec 23, 2024, 1:24 PM BST
-25.91%
Market Cap 6.94M
Revenue (ttm) n/a
Net Income (ttm) -2.70M
Shares Out 396.39M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,206,039
Open 1.700
Previous Close 1.750
Day's Range 1.525 - 1.725
52-Week Range 1.420 - 3.380
Beta 0.38
Analysts n/a
Price Target n/a
Earnings Date Apr 25, 2025

About LON: CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.